- Home
- NSP vs ELVN Comparison
NSP vs ELVN Comparison
Compare NSP & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NSP | ELVN |
|---|---|---|
| Founded | 1986 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 2.2B |
| IPO Year | 1996 | 2020 |
Fundamental Metrics
Financial Performance| Metric | NSP | ELVN |
|---|---|---|
| Price | $48.35 | $52.95 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | ★ $47.67 | $43.40 |
| AVG Volume (30 Days) | 591.0K | ★ 1.3M |
| Earning Date | 04-30-2026 | 05-11-2026 |
| Dividend Yield | ★ 6.45% | N/A |
| EPS Growth | N/A | ★ 3.17 |
| EPS | ★ 0.88 | N/A |
| Revenue | ★ $6,812,000,000.00 | N/A |
| Revenue This Year | $3.45 | N/A |
| Revenue Next Year | $6.95 | N/A |
| P/E Ratio | $54.52 | ★ N/A |
| Revenue Growth | ★ 3.51 | N/A |
| 52 Week Low | $18.57 | $14.79 |
| 52 Week High | $61.65 | $54.88 |
Technical Indicators
Market Signals| Indicator | NSP | ELVN |
|---|---|---|
| Relative Strength Index (RSI) | 62.54 | 60.03 |
| Support Level | $32.75 | $25.63 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 2.38 | 2.43 |
| MACD | -0.17 | -0.20 |
| Stochastic Oscillator | 66.08 | 70.44 |
Price Performance
Historical ComparisonAbout NSP Insperity Inc.
Insperity Inc is a company that provides a wide range of human resources and business solutions designed to help businesses improve their performance. Small and midsize enterprises are the company's primary target customers. Majority of the company's products are offered through the company's Workforce Optimization and Workforce Synchronization solutions, which comprise various human resource functions, such as payroll and employment administration, employee benefits and compensation, government compliance, performance management, training and development services, and human capital management. The company generates all of its revenue in the United States.
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. The product candidates of the company include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.